Health Condition 1: H108- Other conjunctivitis
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Males or females 4 to 18 years of age. 2. Active VKC 3. Patients were required to have experienced 1 or more recurrences of VKC during the previous year. 4. Only the patients (or patientâ??s guardian) who consent to be included in the study and sign on the consent form attached as annexure 1 will be included in the study.
Exclusion criteria
Exclusion criteria: 1. Patients will be excluded if they demonstrated ocular anomalies other than VKC affecting the ocular surface. 2. Abnormalities of lid anatomic features, nasolacrimal drainage, or blinking function. 3. Active ocular infection or history of ocular herpes, varicella zoster or vaccinia virus infection. 4. Any ocular disease that would require topical ocular treatment during the study. 5. Presence or history of severe systemic allergy at study entry. 6. Topical or systemic corticosteroids within 1 week; topical or systemic immunosuppressive drug within 90 days before enrolment. 7. Scraping of the vernal plaque within 1 month; or any other ocular surgery within 6 months before baseline.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Relieve in watering, itching, photophobia and burning sensation Timepoint: The patients will be assessed on 1oth day, 21st day and 30th day after commencing treatment. | — |
Secondary
| Measure | Time frame |
|---|---|
| To compare rescue medicine intake in patients treated with Guduchi Ghrita eye drops or with SCG 2% eye drops in VKC patients. Timepoint: The patients will be assessed on 1oth day, 21st day and 30th day after commencing treatment. | — |
Countries
India
Contacts
Banaras Hindu University